Medindia

X

The Quantum Group, Inc. Announces Separation of Units

Friday, January 11, 2008 General News J E 4
Advertisement
WELLINGTON, Fla., Jan. 10 The Quantum Group,Inc. (Amex: QGP, QGP.U) (www.QuantumMD.com) today announced that it has beennotified by Paulson Investment Company, a wholly owned subsidiary of PaulsonCapital Corp. (Nasdaq: PLCC) and the lead underwriter for the December 2007public offering, that beginning Monday, January 14, 2008, the Company unitswill separate into its individual component parts; three shares of commonstock, two Class A warrants and two Class B warrants. The units, tradingunder the symbol QGP.U, will cease to trade as of the close of business onFriday, January 11, 2008. The separation of the units will be voluntary fromMonday, January 14, 2008 to Wednesday, January 16, 2008.

At the open of the market on Monday, January 14, 2008, unit holders mayseparately trade the common stock, Class A warrants and Class B warrantsincluded in such units. The symbols for the common stock, Class A warrantsand Class B warrants are QGP, QGP.WS.A and QGP.WS.B, respectively.

About the Company

The Quantum Group, Inc. is a Florida-based organization. The Companybuilds and manages healthcare systems and offers consulting and outsourcingservices that will be leveraged by leading-edge technology to the nation'slargest and fastest growing industry- healthcare.

The Company is engaged in the development and execution of a series ofinnovative technology initiatives designed to make Quantum one of the state'sleading providers of business solutions for the healthcare industry. Throughits growing number of nearly 1,600 contracted physicians and managed carerelationships in the state of Florida, the Company believes it is positionedto bring increased efficiencies to the Florida healthcare industry.

Certain statements contained in this news release, which are not based onhistorical facts, are forward-looking statements as the term is defined in thePrivate Securities Litigation Reform Act of 1995, and are subject tosubstantial uncertainties and risks in part detailed in the respectivecompany's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-Kfilings (and amendments thereto) that may cause actual results to materiallydiffer from projections. Forward-looking statements can be identified by theuse of words such as "expects," "plans," "will," "may," "anticipates,""believes," "should," "intends," "estimates" and other words of similarmeaning. These statements are subject to risks and uncertainties that cannotbe predicted or quantified and, consequently, actual results may differmaterially from those expressed or implied by these forward-lookingstatements. Such risk factors include, without limitation, the ability of theCompany to properly execute its business model, to raise substantial andimmediate additional capital to implement its business model, to attract andretain executive, management and operational personnel, to negotiate favorablecurrent debt and future capital raises, to negotiate favorable agreements witha diversified provider base and to continue to supply the services needed byits HMO clients as well physician clients. The Company does not undertake anyobligation to publicly update any forward-looking statements. As a result,investors should not place undue reliance on these forward-looking statements.FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group, LLC Daniel Conway, Chief Strategist 407.585.1080 or via email at Quantum@efcg.net Or Danielle Amodio Vice President, Corporate Communications The Quantum Group, Inc. 561.798.9800

SOURCE The Quantum Group, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Cardinal Health Taps Teva Executive George Barrett...
S
NutraCea Forms Joint Ventures With HerbalScience t...